Concepedia

Matthew W. Vanneman

MW

Statistics

Publications

9

Citations

825

H-Index

9

Active since

2008

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Massachusetts General Hospital

Dana-Farber Brigham Cancer Center

Matthew W. Vanneman is an author at Harvard University specializing in medicine, immunology, and cancer immunology.

Publications per year

2008–2022

9

Publications

9

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

Masahisa Jinushi, Matthew W. Vanneman, Nikhil C. Munshi et al. · Proceedings of the National Academy of Sciences · 2008 · 251 citations · Full text

Life Sciences, Immunology, Pathology +17

Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model

Baochun Zhang, Sven Kracker, Tomoharu Yasuda et al. · Cell · 2012 · 174 citations · Full text

Medicine, Immunology, Oncology +14

IAP inhibitors enhance co-stimulation to promote tumor immunity

Michael Dougan, Stephanie K. Dougan, Joanna Slisz et al. · The Journal of Experimental Medicine · 2010 · 148 citations · Full text

Life Sciences, Immunology, Oncology +17

Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation

Vincent T. Ho, Matthew W. Vanneman, Haesook Kim et al. · Proceedings of the National Academy of Sciences · 2009 · 108 citations · Full text

Medicine, Immunology, Oncology +17

Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction

Catia Fonseca, Robert J. Soiffer, Vincent T. Ho et al. · Blood · 2008 · 37 citations · Full text

Medicine, Immunology, Oncology +16

1–5 of 9